PeptideStack
5.2kquestions
20kanswers
220users

What did the placebo arm of SURMOUNT-5 report for dizziness?

Asked 3 Apr 2024Modified 2.3 years agoViewed 27k times
29

Conditions: SURMOUNT-5 · dizziness.

The figures are clear enough; the question is what they mean and what they do not.

I can supply the numbers if the specifics change the answer.

How should I read this, and where are the traps?

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
shareeditfollowflag
MI
askedmicron2222k383 Apr 2024
3Can you link the publication rather than the summary? The summary usually drops the interval. – meniscus_film 9 months ago
4Is this the randomised phase or the open-label extension? – coldpack_88 22 days ago
add a comment

No answers yet

This question has not been answered. It has been viewed 27k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.